Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approach

17 Dec 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to interferon and immune responses
Share to SARS-CoV-2 and COVID-19 Research
Share to vaccines and immunoinformatics approaches

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33346100
DOI: 10.1016/j.gene.2020.145368

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approachPMID 33346100Read ↗

Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approachSemantic proximity Read ↗

Large-Scale Multi-omic Analysis of COVID-19 SeveritySemantic proximity Read ↗

Multiomics Evaluation of Gastrointestinal and Other Clinical Characteristics of COVID-19.Semantic proximity Read ↗

Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19Semantic proximity Read ↗

Safeguarding COVID-19 and cancer management: drug design and therapeutic approachSemantic proximity Read ↗

Integrative clinical, genomics and metabolomics data analysis for mainstream precision medicine to investigate COVID-19Semantic proximity Read ↗

Drug-repurposing against COVID-19 by targeting a key signaling pathway: An in silico studySemantic proximity Read ↗

An Overview of SARS-CoV-2 Potential Targets, Inhibitors, and Computational Insights to Enrich the Promising Treatment StrategiesSemantic proximity Read ↗

Application of omics technology to combat the COVID‐19 pandemicSemantic proximity Read ↗

Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discoverySemantic proximity Read ↗

Translating GWAS Findings to Inform Drug Repositioning Strategies for COVID-19 TreatmentSemantic proximity Read ↗

Understanding COVID-19 through genome-wide association studies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.